Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2019

Main Data: 31/12 Year 2019
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
– total revenues 1,595.5
– industrial gross profit 581.2
– total operating cost 388.7
– operating profit 192.5
– net financial income 36.6
– profit attributable to equity holders of the parent 169.2

 

Consolidated balance sheet Millions / Euro
– working capital  143.0
– non-current assets  1,220.7
– provision for severance indemnities and other provisions -221.7
– net debt -637.1
– equity pertaining to the group and minority interests 504.9

 

Other information Millions / Euro
– depreciation, amortization and impairment 81.6
– R & D costs 53.9

 

  Euro
Dividend per share 2.0

 

  No.
Employees 5,949

 

  Euro
Share capital 22,470,504,68

 

Net Sales By Sector: Year 2019
  Millions/Euro  
tea, food & other 804.6 50.4%
pharmaceutical 699.6 43.9%
tobacco packaging 91.3 5.7%
Total 1,595.5 100.0%

 

Net Sales by Country: Year 2019
  Millions/Euro  
E.U. (excluding Italy) 451.3 28.3%
Other European countries 109.1 6.8%
North America 313.7 19.7%
Asia & Middle East 354.7 22.2%
Other countries 173.9 10.9%
Total exports 1,402.7 87.9%
Italy 192.8 12.1%
Total 1,595.5 100.0%

 

Main Data: 30/06 Year 2019
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenue 694.1
– industrial gross profit 242.4
– total operating cost 186.6
– operating profit 55.8
– net financial expense 12.4
– profit attributable to equity holders of the parent 31.1

 

Consolidated balance sheet Millions/Euro
– working capital 108.5
– non-current assets 812.5
– provision for severance indemnities and other provisions -136.4
– net debt -423.5
– equity pertaining to the group and minority interests 361.1

 

Other information Millions/Euro
– depreciation and amortization 35.3
– R & D costs 27.3

 

  No.
Employees 5,755

 

  Euro
Share capital 20,415,200